Literature DB >> 9781904

Molecular genetics of Wiedemann-Beckwith syndrome.

M Li1, J A Squire, R Weksberg.   

Abstract

Wiedemann-Beckwith syndrome (WBS) is a heterogeneous overgrowth syndrome associated with malformations and an elevated risk of developing embryonal tumors. WBS is a multigenic disorder caused by dysregulation of imprinted growth regulatory genes within the 11p15 region. Elucidation of the genetic cause of WBS will provide important insights into the molecular and epigenetic changes associated with loss of normal growth control and cancer in this syndrome. Currently available protocols for diagnostic testing, patient monitoring and genetic counselling will evolve as our understanding of the molecular basis of WBS progresses.

Entities:  

Mesh:

Year:  1998        PMID: 9781904

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  24 in total

Review 1.  Hyperinsulinism and Beckwith-Wiedemann syndrome.

Authors:  C F Munns; J A Batch
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-01       Impact factor: 5.747

2.  Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.

Authors:  R G Weber; T Pietsch; D von Schweinitz; P Lichter
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  Lower expression of ATM and gene deletion is more frequent in adrenocortical carcinomas than adrenocortical adenomas.

Authors:  Junna Ye; Yan Qi; Weiqing Wang; Fukang Sun; Qin Wei; Tingwei Su; Weiwei Zhou; Yiran Jiang; Wenqi Yuan; Jianfei Cai; Bin Cui; Guang Ning
Journal:  Endocrine       Date:  2012-02-04       Impact factor: 3.633

Review 4.  A diagnostic approach to adrenal cortical lesions.

Authors:  Anne Marie McNicol
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

5.  A maternally methylated CpG island in KvLQT1 is associated with an antisense paternal transcript and loss of imprinting in Beckwith-Wiedemann syndrome.

Authors:  N J Smilinich; C D Day; G V Fitzpatrick; G M Caldwell; A C Lossie; P R Cooper; A C Smallwood; J A Joyce; P N Schofield; W Reik; R D Nicholls; R Weksberg; D J Driscoll; E R Maher; T B Shows; M J Higgins
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-06       Impact factor: 11.205

6.  Molecular and genomic characterisation of cryptic chromosomal alterations leading to paternal duplication of the 11p15.5 Beckwith-Wiedemann region.

Authors:  S Russo; P Finelli; M P Recalcati; S Ferraiuolo; F Cogliati; B Dalla Bernardina; M G Tibiletti; M Agosti; M Sala; M T Bonati; L Larizza
Journal:  J Med Genet       Date:  2006-08       Impact factor: 6.318

7.  Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p.

Authors:  S C Abraham; T T Wu; D S Klimstra; L S Finn; J H Lee; C J Yeo; J L Cameron; R H Hruban
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

Review 8.  [Cystic lesions of the pancreas].

Authors:  U Rosien; P Layer
Journal:  Med Klin (Munich)       Date:  1999-07-15

9.  Alterations of RB1 gene in embryonal and alveolar rhabdomyosarcoma: special reference to utility of pRB immunoreactivity in differential diagnosis of rhabdomyosarcoma subtype.

Authors:  Kenichi Kohashi; Yoshinao Oda; Hidetaka Yamamoto; Sadafumi Tamiya; Tomonari Takahira; Yukiko Takahashi; Tatsuro Tajiri; Tomoaki Taguchi; Sachiyo Suita; Masazumi Tsuneyoshi
Journal:  J Cancer Res Clin Oncol       Date:  2008-04-02       Impact factor: 4.553

10.  Loss of CpG methylation is strongly correlated with loss of histone H3 lysine 9 methylation at DMR-LIT1 in patients with Beckwith-Wiedemann syndrome.

Authors:  Ken Higashimoto; Takeshi Urano; Kazumitsu Sugiura; Hitomi Yatsuki; Keiichiro Joh; Wei Zhao; Mayumi Iwakawa; Hirofumi Ohashi; Mitsuo Oshimura; Norio Niikawa; Tsunehiro Mukai; Hidenobu Soejima
Journal:  Am J Hum Genet       Date:  2003-08-29       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.